New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2014
08:57 EDTAMAGAMAG Pharmaceuticals price target lowered to $30 from $43 at Summer Street
Summer Street lowered its price target for AMAG Pharmaceuticals to $30 following the company's complete response letter for a broader indication of Feraheme. The firm keeps a Buy rating on the stock.
News For AMAG From The Last 14 Days
Check below for free stories on AMAG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2014
15:32 EDTAMAGBroadfin Capital reports 6.55% passive stake in AMAG Pharmaceuticals

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use